Plasma Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Pure Prp, Leukocyte-Rich Prp, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin); Source (Autologous, Allogenic); Application (Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury, Others) and Geography

Report Code: TIPRE00021907 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Plasma therapy is one of the conservative techniques that is majorly used in dentistry, orthopedic, and dermatologic specialties. Plasma therapeutics finds its extensive applications in wound healing, face rejuvenation and androgenetic alopecia. Healing is facilitated when high concentrated plasma, up to 3-5 times of its physiologic value is injected into the patients' tissues.

MARKET DYNAMICS

The Plasma Therapeutics market is driving due to the rising geriatric population and increasing demand for minimally invasive therapies. In addition, rising number of patients suffering from orthopedic disorders and androgenic alopecia is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Plasma Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with/ a special focus on the global market trend analysis. The report aims to provide an overview of Plasma Therapeutics market with detailed market segmentation by type, source, application and geography. The Plasma Therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Plasma Therapeutics market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Plasma Therapeutics market is segmented into type, source, application. Based on type, the market is segmented as, Pure Prp, Leukocyte-Rich Prp, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin. Based on source, the market is segmented in to Autologous, And Allogenic. On the basis of application, the plasma therapy market is categorized as per Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury, and others

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Plasma Therapeutics Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Plasma Therapeutics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Plasma Therapeutics Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the Plasma Therapeutics Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Plasma Therapeutics Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Plasma Therapeutics Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Plasma Therapeutics Market in the global market. Below mentioned is the list of few companies engaged in the Plasma Therapeutics market.

The report also includes the profiles of key players in Plasma Therapeutics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Terumo BCT, Inc
  •   Biolife Plasma Services
  •   The LFB Group
  •   Cambryn Biologics
  •   CSL Limited
    6. Kedrion S. p. A
    7. Grifols, S. A.
  •   Bio Products Laboratory Ltd.
  •   China Biologic Products Holdings, Inc.
  •   Octapharma
    11. Biotest AG
    12. Baxter
    13. Shire Plc
    14. ADMA Biologics, Inc.
    15. Takeda Pharmaceutical Company Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1.INTRODUCTION
1.1.SCOPE OF THE STUDY
1.2.THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3.MARKET SEGMENTATION
1.3.1Plasma Therapeutics Market - By Type
1.3.2Plasma Therapeutics Market - By Source
1.3.3Plasma Therapeutics Market - By Application
1.3.4Plasma Therapeutics Market - By Region
1.3.4.1By Country

2.KEY TAKEAWAYS

3.RESEARCH METHODOLOGY

4.PLASMA THERAPEUTICS MARKET LANDSCAPE
4.1.OVERVIEW
4.2.PEST ANALYSIS
4.2.1North America - Pest Analysis
4.2.2Europe - Pest Analysis
4.2.3Asia-Pacific - Pest Analysis
4.2.4Middle East and Africa - Pest Analysis
4.2.5South and Central America - Pest Analysis
4.3.EXPERT OPINIONS

5.PLASMA THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1.KEY MARKET DRIVERS
5.2.KEY MARKET RESTRAINTS
5.3.KEY MARKET OPPORTUNITIES
5.4.FUTURE TRENDS
5.5.IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6.PLASMA THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1.PLASMA THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2.PLASMA THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3.MARKET POSITIONING

7.PLASMA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 â" TYPE
7.1.OVERVIEW
7.2.TYPE MARKET FORECASTS AND ANALYSIS
7.3.PURE PRP
7.3.1.Overview
7.3.2.Pure Prp Market Forecast and Analysis
7.4.LEUKOCYTE-RICH PRP
7.4.1.Overview
7.4.2.Leukocyte-Rich Prp Market Forecast and Analysis
7.5.PURE PLATELET-RICH FIBRIN
7.5.1.Overview
7.5.2.Pure Platelet-Rich Fibrin Market Forecast and Analysis
7.6.LEUKOCYTE-RICH FIBRIN
7.6.1.Overview
7.6.2.Leukocyte-Rich Fibrin Market Forecast and Analysis
8.PLASMA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 â" SOURCE
8.1.OVERVIEW
8.2.SOURCE MARKET FORECASTS AND ANALYSIS
8.3.AUTOLOGOUS
8.3.1.Overview
8.3.2.Autologous Market Forecast and Analysis
8.4.ALLOGENIC
8.4.1.Overview
8.4.2.Allogenic Market Forecast and Analysis
9.PLASMA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 â" APPLICATION
9.1.OVERVIEW
9.2.APPLICATION MARKET FORECASTS AND ANALYSIS
9.3.ORTHOPEDIC
9.3.1.Overview
9.3.2.Orthopedic Market Forecast and Analysis
9.4.DERMATOLOGY
9.4.1.Overview
9.4.2.Dermatology Market Forecast and Analysis
9.5.CARDIAC MUSCLE INJURY
9.5.1.Overview
9.5.2.Cardiac Muscle Injury Market Forecast and Analysis
9.6.DENTAL
9.6.1.Overview
9.6.2.Dental Market Forecast and Analysis
9.7.NERVE INJURY
9.7.1.Overview
9.7.2.Nerve Injury Market Forecast and Analysis
9.8.OTHERS
9.8.1.Overview
9.8.2.Others Market Forecast and Analysis

10.PLASMA THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2028 â" GEOGRAPHICAL ANALYSIS
10.1.NORTH AMERICA
10.1.1North America Plasma Therapeutics Market Overview
10.1.2North America Plasma Therapeutics Market Forecasts and Analysis
10.1.3North America Plasma Therapeutics Market Forecasts and Analysis - By Type
10.1.4North America Plasma Therapeutics Market Forecasts and Analysis - By Source
10.1.5North America Plasma Therapeutics Market Forecasts and Analysis - By Application
10.1.6North America Plasma Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1United States Plasma Therapeutics Market
10.1.6.1.1United States Plasma Therapeutics Market by Type
10.1.6.1.2United States Plasma Therapeutics Market by Source
10.1.6.1.3United States Plasma Therapeutics Market by Application
10.1.6.2Canada Plasma Therapeutics Market
10.1.6.2.1Canada Plasma Therapeutics Market by Type
10.1.6.2.2Canada Plasma Therapeutics Market by Source
10.1.6.2.3Canada Plasma Therapeutics Market by Application
10.1.6.3Mexico Plasma Therapeutics Market
10.1.6.3.1Mexico Plasma Therapeutics Market by Type
10.1.6.3.2Mexico Plasma Therapeutics Market by Source
10.1.6.3.3Mexico Plasma Therapeutics Market by Application
10.2.EUROPE
10.2.1Europe Plasma Therapeutics Market Overview
10.2.2Europe Plasma Therapeutics Market Forecasts and Analysis
10.2.3Europe Plasma Therapeutics Market Forecasts and Analysis - By Type
10.2.4Europe Plasma Therapeutics Market Forecasts and Analysis - By Source
10.2.5Europe Plasma Therapeutics Market Forecasts and Analysis - By Application
10.2.6Europe Plasma Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1Germany Plasma Therapeutics Market
10.2.6.1.1Germany Plasma Therapeutics Market by Type
10.2.6.1.2Germany Plasma Therapeutics Market by Source
10.2.6.1.3Germany Plasma Therapeutics Market by Application
10.2.6.2France Plasma Therapeutics Market
10.2.6.2.1France Plasma Therapeutics Market by Type
10.2.6.2.2France Plasma Therapeutics Market by Source
10.2.6.2.3France Plasma Therapeutics Market by Application
10.2.6.3Italy Plasma Therapeutics Market
10.2.6.3.1Italy Plasma Therapeutics Market by Type
10.2.6.3.2Italy Plasma Therapeutics Market by Source
10.2.6.3.3Italy Plasma Therapeutics Market by Application
10.2.6.4Spain Plasma Therapeutics Market
10.2.6.4.1Spain Plasma Therapeutics Market by Type
10.2.6.4.2Spain Plasma Therapeutics Market by Source
10.2.6.4.3Spain Plasma Therapeutics Market by Application
10.2.6.5United Kingdom Plasma Therapeutics Market
10.2.6.5.1United Kingdom Plasma Therapeutics Market by Type
10.2.6.5.2United Kingdom Plasma Therapeutics Market by Source
10.2.6.5.3United Kingdom Plasma Therapeutics Market by Application
10.2.6.6Rest of Europe Plasma Therapeutics Market
10.2.6.6.1Rest of Europe Plasma Therapeutics Market by Type
10.2.6.6.2Rest of Europe Plasma Therapeutics Market by Source
10.2.6.6.3Rest of Europe Plasma Therapeutics Market by Application
10.3.ASIA-PACIFIC
10.3.1Asia-Pacific Plasma Therapeutics Market Overview
10.3.2Asia-Pacific Plasma Therapeutics Market Forecasts and Analysis
10.3.3Asia-Pacific Plasma Therapeutics Market Forecasts and Analysis - By Type
10.3.4Asia-Pacific Plasma Therapeutics Market Forecasts and Analysis - By Source
10.3.5Asia-Pacific Plasma Therapeutics Market Forecasts and Analysis - By Application
10.3.6Asia-Pacific Plasma Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1Australia Plasma Therapeutics Market
10.3.6.1.1Australia Plasma Therapeutics Market by Type
10.3.6.1.2Australia Plasma Therapeutics Market by Source
10.3.6.1.3Australia Plasma Therapeutics Market by Application
10.3.6.2China Plasma Therapeutics Market
10.3.6.2.1China Plasma Therapeutics Market by Type
10.3.6.2.2China Plasma Therapeutics Market by Source
10.3.6.2.3China Plasma Therapeutics Market by Application
10.3.6.3India Plasma Therapeutics Market
10.3.6.3.1India Plasma Therapeutics Market by Type
10.3.6.3.2India Plasma Therapeutics Market by Source
10.3.6.3.3India Plasma Therapeutics Market by Application
10.3.6.4Japan Plasma Therapeutics Market
10.3.6.4.1Japan Plasma Therapeutics Market by Type
10.3.6.4.2Japan Plasma Therapeutics Market by Source
10.3.6.4.3Japan Plasma Therapeutics Market by Application
10.3.6.5South Korea Plasma Therapeutics Market
10.3.6.5.1South Korea Plasma Therapeutics Market by Type
10.3.6.5.2South Korea Plasma Therapeutics Market by Source
10.3.6.5.3South Korea Plasma Therapeutics Market by Application
10.3.6.6Rest of Asia-Pacific Plasma Therapeutics Market
10.3.6.6.1Rest of Asia-Pacific Plasma Therapeutics Market by Type
10.3.6.6.2Rest of Asia-Pacific Plasma Therapeutics Market by Source
10.3.6.6.3Rest of Asia-Pacific Plasma Therapeutics Market by Application
10.4.MIDDLE EAST AND AFRICA
10.4.1Middle East and Africa Plasma Therapeutics Market Overview
10.4.2Middle East and Africa Plasma Therapeutics Market Forecasts and Analysis
10.4.3Middle East and Africa Plasma Therapeutics Market Forecasts and Analysis - By Type
10.4.4Middle East and Africa Plasma Therapeutics Market Forecasts and Analysis - By Source
10.4.5Middle East and Africa Plasma Therapeutics Market Forecasts and Analysis - By Application
10.4.6Middle East and Africa Plasma Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1South Africa Plasma Therapeutics Market
10.4.6.1.1South Africa Plasma Therapeutics Market by Type
10.4.6.1.2South Africa Plasma Therapeutics Market by Source
10.4.6.1.3South Africa Plasma Therapeutics Market by Application
10.4.6.2Saudi Arabia Plasma Therapeutics Market
10.4.6.2.1Saudi Arabia Plasma Therapeutics Market by Type
10.4.6.2.2Saudi Arabia Plasma Therapeutics Market by Source
10.4.6.2.3Saudi Arabia Plasma Therapeutics Market by Application
10.4.6.3U.A.E Plasma Therapeutics Market
10.4.6.3.1U.A.E Plasma Therapeutics Market by Type
10.4.6.3.2U.A.E Plasma Therapeutics Market by Source
10.4.6.3.3U.A.E Plasma Therapeutics Market by Application
10.4.6.4Rest of Middle East and Africa Plasma Therapeutics Market
10.4.6.4.1Rest of Middle East and Africa Plasma Therapeutics Market by Type
10.4.6.4.2Rest of Middle East and Africa Plasma Therapeutics Market by Source
10.4.6.4.3Rest of Middle East and Africa Plasma Therapeutics Market by Application
10.5.SOUTH AND CENTRAL AMERICA
10.5.1South and Central America Plasma Therapeutics Market Overview
10.5.2South and Central America Plasma Therapeutics Market Forecasts and Analysis
10.5.3South and Central America Plasma Therapeutics Market Forecasts and Analysis - By Type
10.5.4South and Central America Plasma Therapeutics Market Forecasts and Analysis - By Source
10.5.5South and Central America Plasma Therapeutics Market Forecasts and Analysis - By Application
10.5.6South and Central America Plasma Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1Brazil Plasma Therapeutics Market
10.5.6.1.1Brazil Plasma Therapeutics Market by Type
10.5.6.1.2Brazil Plasma Therapeutics Market by Source
10.5.6.1.3Brazil Plasma Therapeutics Market by Application
10.5.6.2Argentina Plasma Therapeutics Market
10.5.6.2.1Argentina Plasma Therapeutics Market by Type
10.5.6.2.2Argentina Plasma Therapeutics Market by Source
10.5.6.2.3Argentina Plasma Therapeutics Market by Application
10.5.6.3Rest of South and Central America Plasma Therapeutics Market
10.5.6.3.1Rest of South and Central America Plasma Therapeutics Market by Type
10.5.6.3.2Rest of South and Central America Plasma Therapeutics Market by Source
10.5.6.3.3Rest of South and Central America Plasma Therapeutics Market by Application

11.INDUSTRY LANDSCAPE
11.1.MERGERS AND ACQUISITIONS
11.2.AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3.NEW PRODUCT LAUNCHES
11.4.EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12.PLASMA THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1.TERUMO BCT, INC
12.1.1.Key Facts
12.1.2.Business Description
12.1.3.Products and Services
12.1.4.Financial Overview
12.1.5.SWOT Analysis
12.1.6.Key Developments
12.2.BIOLIFE PLASMA SERVICES
12.2.1.Key Facts
12.2.2.Business Description
12.2.3.Products and Services
12.2.4.Financial Overview
12.2.5.SWOT Analysis
12.2.6.Key Developments
12.3.THE LFB GROUP
12.3.1.Key Facts
12.3.2.Business Description
12.3.3.Products and Services
12.3.4.Financial Overview
12.3.5.SWOT Analysis
12.3.6.Key Developments
12.4.CAMBRYN BIOLOGICS
12.4.1.Key Facts
12.4.2.Business Description
12.4.3.Products and Services
12.4.4.Financial Overview
12.4.5.SWOT Analysis
12.4.6.Key Developments
12.5.CSL LIMITED
12.5.1.Key Facts
12.5.2.Business Description
12.5.3.Products and Services
12.5.4.Financial Overview
12.5.5.SWOT Analysis
12.5.6.Key Developments
12.6.KEDRION S. P. A
12.6.1.Key Facts
12.6.2.Business Description
12.6.3.Products and Services
12.6.4.Financial Overview
12.6.5.SWOT Analysis
12.6.6.Key Developments
12.7.GRIFOLS, S. A.
12.7.1.Key Facts
12.7.2.Business Description
12.7.3.Products and Services
12.7.4.Financial Overview
12.7.5.SWOT Analysis
12.7.6.Key Developments
12.8.BIO PRODUCTS LABORATORY LTD.
12.8.1.Key Facts
12.8.2.Business Description
12.8.3.Products and Services
12.8.4.Financial Overview
12.8.5.SWOT Analysis
12.8.6.Key Developments
12.9.CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
12.9.1.Key Facts
12.9.2.Business Description
12.9.3.Products and Services
12.9.4.Financial Overview
12.9.5.SWOT Analysis
12.9.6.Key Developments
12.10.OCTAPHARMA
12.10.1.Key Facts
12.10.2.Business Description
12.10.3.Products and Services
12.10.4.Financial Overview
12.10.5.SWOT Analysis
12.10.6.Key Developments

13.APPENDIX
13.1.ABOUT THE INSIGHT PARTNERS
13.2.GLOSSARY OF TERMS
The List of Companies

1. Terumo BCT, Inc
2. Biolife Plasma Services
3. The LFB Group
4. Cambryn Biologics
5. CSL Limited
6. Kedrion S. p. A
7. Grifols, S. A.
8. Bio Products Laboratory Ltd.
9. China Biologic Products Holdings, Inc.
10. Octapharma
11. Biotest AG
12. Baxter
13. Shire Plc
14. ADMA Biologics, Inc.
15. Takeda Pharmaceutical Company Ltd.
TIPRE00021907
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking